HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary Sjögren's syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia.

Abstract
Primary Sjögren's syndrome (PSS) is associated with increased risk of lymphoproliferative malignancy, and B-cell non-Hodgkin lymphoma (B-NHL) is the most frequent type. To evaluate CD4+ T lymphocytes distributions in patients with (PSS) and the association of CD4+ T lymphocytopenia with the development of (B-NHL), this study included 8 (PSS) patients associated with B-NHL (group I), 50 (pSS) patients without B-NHL (group II), and 30 healthy volunteers who served as controls. The frequency of circulating CD4+ and CD8+ T lymphocytes distributions and CD4+/CD8+ T cell ratio was assessed using flow cytometry coulter EPICS-XL and compared between patients groups and controls. There was statistically significant CD4+ T lymphocytopenia in (PSS) patients with B-NHL than those without lymphoma and controls (P = 0.001). Moreover, a significant low CD4+/CD8+ T cell ratio 0.8 in group I than group II and controls (P = 0.001) was found. Significant positive correlations of CD4+ T lymphocytopenia with other risk factors (parotid swelling, vasculitis, rheumatoid factors, low complement, cryoglobulinemia) were detected. CD4+ T lymphocytopenia is associated with B-NHL developed in patients with PSS and can be considered as an important predictor of lymphoma.
AuthorsFaten Ismail, Amel Mahmoud, Hisham Abdelhaleem, Amro Mamdoh, M Geneidy, Enas Kamal
JournalRheumatology international (Rheumatol Int) Vol. 33 Issue 4 Pg. 1021-5 (Apr 2013) ISSN: 1437-160X [Electronic] Germany
PMID22886469 (Publication Type: Journal Article)
Topics
  • Adult
  • CD4-Positive T-Lymphocytes (immunology, pathology)
  • Female
  • Humans
  • Lymphocyte Count
  • Lymphoma, Non-Hodgkin (etiology, immunology, pathology)
  • Male
  • Middle Aged
  • Risk Factors
  • Sjogren's Syndrome (etiology, immunology, pathology)
  • T-Lymphocytopenia, Idiopathic CD4-Positive (complications, immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: